| abstract |
The present invention relates to substituted 2- (morpholin-4-yl) -1, 7-naphthyridine compounds represented by general formula (i) or (ib), processes for the preparation of said compounds, intermediates useful for the preparation of said compounds, on combinations and pharmaceutical compositions comprising said compounds and on the use of said compounds for the manufacture of a pharmaceutical composition useful for the treatment or prophylaxis of a disease, in particular of a hyperproliferative disease in as a single agent or in combination with other active ingredients. |